Sees FY25 revenue $64.1B-$65.6B, consensus $67.36B.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRK:
- Notable companies reporting before tomorrow’s open
- MRK Upcoming Earnings Report: What to Expect?
- Merck’s capvaxive receives positive EU CHMP opinion for pneumococcal vaccine
- Kennedy says he will give away rights to fees from vaccine litigation, NYT says
- NVS Earnings: Entresto Drugmaker Novartis Tops Estimates as Patent Expiry Looms